亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

濟南偉都化工有限公司  

醫藥原料藥和醫藥中間體

搜索
新聞中心
產品分類
  • 暫無分類
聯系方式
  • 聯系人:姚銳
  • 電話:0531-88873471
  • 郵件:wedochem@gmail.com
  • 傳真:0531-88873470
  • QQ:1783747865
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 702-82-9
702-82-9
單價 面議對比
詢價 暫無
發貨 山東濟南市付款后3天內
品牌 偉都化工
型號 702-82-9
規格 99%
過期 長期有效
更新 2013-11-25 11:41
 
詳細信息
 3-氨基-1-金剛烷醇 702-82-9
中文別名: 3-氨基金剛烷醇; 3-胺基-1-金剛烷醇; 1-氨基-3-羥基金剛烷  
英文名稱: 3-Amino-1-adamantanol 
英文別名: 1-amino-3-Hydroxyadamantane; 3-Amino-1-adamantanol; 3-aminoadamantan-1-ol; 3-Amino-1-Hydroxyadamantane; 3-aminotricyclo[3.3.1.1~3,7~]decan-1-ol 
CAS號: 702-82-9 
分子式: C10H17NO 
分子量: 167.2481  
InChI: InChI=1/C10H17NO/c11-9-2-7-1-8(3-9)5-10(12,4-7)6-9/h7-8,12H,1-6,11H2  
用途:維達列汀中間體
©2025 濟南偉都化工有限公司 版權所有   技術支持:化工網   訪問量:22755  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |